Skip to main content
. 2019 Apr 9;14:100357. doi: 10.1016/j.conctc.2019.100357

Table 1.

Eligibility criteria.

Inclusion criteria
  • Age ≥ 65 years

  • Incident ESKD started on chronic HD within 90 days prior to screening and recovery of kidney function is unlikely

  • Advanced kidney disease expected to require HD initiation within 90 days of screening

  • TCVC is the sole vascular access used for HD

  • Did not undergo prior AV access placement

  • Medically eligible to receive AVF and AVG placement

  • Surgically eligible to receive AVF and AVG placement

  • Ability to provide informed consent

  • HD is the intended long-term modality of treatment for ESKD

  • Anticipated ability to comply with study procedures

  • Planning to remain within Wake Forest provided health care for at least 12 months


Exclusion criteria
  • Presence of an AVF or AVG

  • Previous attempt(s) for AV vascular access placement

  • Native vasculature not suitable for placement of AVF

  • Imminent kidney transplant (expected within 6 months)

  • Anticipated life expectancy <9 months

Abbreviations: ESKD, end-stage kidney disease; HD, hemodialysis; TCVC, tunneled central venous catheter; AV, arteriovenous; AVF, arteriovenous fistula; AVG, arteriovenous graft.